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OBJECTIVES To examine prospectively the association between snoring and incidence of cardiovascular
disease (CVD) in women.
BACKGROUND Whether snoring increases risk of CVD remains unclear; most previous studies have been
small, not prospective and limited to men.
METHODS Seventy-one thousand seven hundred seventy-nine female nurses 40 through 65 years of age
and without previously diagnosed CVD or cancer at baseline in 1986 were followed up for
eight years. Frequency of snoring was assessed using mailed questionnaires at baseline.
RESULTS During eight years of follow-up, we documented 1,042 incident cases of major CVD events
(644 coronary heart disease [CHD] and 398 stroke). Compared with nonsnorers, the
age-adjusted relative risks (RRs) of CVD were 1.46 (95% confidence interval 1.23 to 1.74) for
occasional snorers and 2.02 (1.62 to 2.53) for regular snorers. The age-adjusted RRs of CHD
were 1.43 (1.15 to 1.77) for occasional snorers and 2.18 (1.65 to 2.87) for regular snorers. The
age-adjusted RRs of stroke were 1.60 (1.21 to 2.12) and 1.88 (1.29 to 2.74), respectively.
After further adjustment for smoking, body mass index (BMI) and other covariates, the
positive association between snoring and CVD was attenuated but remained statistically
significant (RRs of CVD were 1.20 [1.01 to 1.43] for occasional snorers and 1.33 [1.06–1.67]
for regular snorers.
CONCLUSIONS These data suggested that snoring is associated with a modest but significantly increased risk
of CVD in women, independent of age, smoking, BMI and other cardiovascular risk factors.
While further study is needed to elucidate the biological mechanism underlying this
association, snoring may help clinicians identify individuals at higher risk for CVD. (J Am
Coll Cardiol 2000;35:308–13) © 2000 by the American College of Cardiology
In some, but not all, epidemiologic studies, regular snoring
has been associated with increased risk of hypertension
(1,2), ischemic heart disease (2–4) and stroke (5–7). The
mechanisms are largely unknown, but probably mediated by
obstructive sleep apnea because heavy snoring almost invari-
ably accompanies sleep apnea (8). Sleep apnea may inde-
pendently increase risk of systemic hypertension (9). In
addition, sleep apnea causes hypoxemia, which promotes
atherosclerosis in experimental studies (10).
However, most snorers do not have sleep apnea. Whether
snoring itself increases risk of hypertension and cardiovas-
cular disease (CVD) remains controversial (8,11,12). Most
previous epidemiological studies of snoring and CVD used
cross-sectional or case-control designs and, therefore, may
be prone to bias because snoring and sleep apnea can be a
consequence of stroke (13). The sole prospective cohort
study of snoring and CVD, which involved only three years
of follow-up, was conducted among men (3). Therefore, we
investigated the association between snoring and incidence
of major CVD during eight years of follow-up among
women enrolled in the Nurses’ Health Study.
METHODS
Study population. The Nurses’ Health Study cohort was
established in 1976 when 121,700 female registered nurses,
married and aged 30 to 55 years and residing in 11 large
U.S. states, completed a mailed questionnaire on their
medical history and lifestyle. Every two years, follow-up
questionnaires have been sent to update information on
potential risk factors and to identify newly diagnosed cases
of coronary and other diseases. On the 1986 questionnaire,
we asked the following: 1) indicate total hours of actual
sleep in a 24-h period (from 5 h or less to 111); 2) what is
your usual sleeping position? (on back, on side, on front); 3)
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do you snore? (regularly, occasionally and never). We
included the 71,779 women 40 to 65 years old and without
diagnosed CVD or cancer in 1986, the baseline year for
these analyses.
All the nurses were married in 1972. We reassessed their
marital status in 1980 (married, divorced or widowed). In
1992, we asked the participants whether they lived with
their spouses or partners.
Ascertainment of end points. The primary end points for
this study were incident cardiovascular events (defined as
nonfatal myocardial infarction [MI] or fatal coronary heart
disease [CHD] and fatal and nonfatal stroke) that occurred
after the return of the 1986 questionnaire but before June 1,
1994. We requested permission to review medical records
from women who reported having a nonfatal MI or stroke
on a follow-up questionnaire. Study physicians with no
knowledge of the self-reported risk factor status reviewed
the records. Nonfatal MI was confirmed if data in the record
met the criteria of the World Health Organization of
symptoms plus either diagnostic electrocardiographic
changes or elevated cardiac enzyme levels (14). Infarctions
that required hospital admission and for which confirmatory
information was obtained by interview or letter, but for
which no medical records were available, were designated as
probable (17%). We included all confirmed and probable
cases in the analyses because results were the same after
excluding probable cases. Stroke was confirmed by medical
records according to the criteria of the National Survey of
Stroke (15), requiring a constellation of neurologic deficits,
sudden or rapid in onset, lasting 24 h or more; events were
further subclassified as hemorrhagic stroke (subarachnoid or
intraparenchymal), ischemic stroke (thrombotic or embolic)
or stroke of unknown cause.
Deaths were reported by next of kin and the postal system
or ascertained through the National Death Index. We
estimate that follow-up information for the deaths was over
98% complete (16). Fatal CHD was confirmed by hospital
records or autopsy or if CHD was listed as the cause of
death on the death certificate and evidence of previous
CHD was available. We designated as presumed fatal CHD
cases those cases in which CHD was the underlying cause
on the death certificate but no records were available. These
cases constituted about 14.7% of fatal CHD cases. We also
included sudden deaths (defined as death within 1 h of onset
of symptoms; 12.3% of fatal CHD). Analyses limited to
confirmed cases yielded very similar results, although with
wider confidence intervals (CI). Fatal strokes were coded
using the same criteria as nonfatal cases, but we accepted
autopsy evidence as well as the death certificate listing of
cause.
Statistical analysis. Person-time for each exposure cate-
gory (never snoring, occasional snoring and regular snoring)
was accumulated, and incidence rates were calculated by
dividing the number of events by person-time of follow-up
in each category. The relative risk (RR) was computed as
the rate in a specific category of the exposure divided by that
in the reference category (nonsnorers) with adjustment for
age. In multivariate analyses using pooled logistic regression
(17), we simultaneously included age (five-year interval),
smoking status (never, past, current smoking of 1 to 14, 15
to 24 and $25 cigarettes per day), body mass index (BMI)
(quintiles), alcohol consumption (0, 1 to 4, 5 to 14, 151
g/day), physical activity (weekly energy expenditure in
metabolic equivalent hours) (18), menopausal status (pre-
menopausal, postmenopausal without hormone replace-
ment, postmenopausal with past hormone replacement,
postmenopausal with current hormone replacement), paren-
tal history of premature MI, history of diabetes or hyper-
cholesterolemia, number of sleeping hours per day and usual
sleeping position. We did not control for history of hyper-
tension in the primary analyses, because snoring has been
associated with risk of hypertension, and thus, the develop-
ment of hypertension may be an intermediate step for the
association between snoring and CVD. In secondary anal-
yses, we also adjusted for hypertension, as well as for the
duration of rotating night shift assessed in 1988 (0, 1 to 5,
6 to 14, 151 years), which has previously been associated
with the risk of CHD in the Nurses’ Health Study (19).
RESULTS
During eight years of follow-up (551,541 person years), we
documented 644 incident cases of CHD and 398 incident
cases of stroke. At baseline, 5% of women reported sleeping
five hours or less a day, 26% 6 h, 41% 7 h, 24% 8 h and 5%
9 h or more. About 81% of women reported usually sleeping
on their side, 7% on their back and 11% on their front; 25%
of women reported never snoring, 65% reported occasional
snoring and 10% regular snoring.
All participants were married in 1972; in 1980, the
majority of women (84%) remained married. The preva-
lence of regular snoring was slightly higher among those
who were divorced or widowed (11%) than those who
remained married (9%). In 1992, 74% of women reported
living with their spouses or partners. The prevalence of
regular snoring was similar between those living with
spouses or partners (9%) and those not living with spouses
or partners (10%).
Women who reported snoring regularly were more likely
to sleep on their back, smoke cigarettes, use alcohol and
have longer duration of night shift work (Table 1). They
Abbreviations and Acronyms
BMI 5 body mass index
CHD 5 coronary heart disease
CI 5 confidence interval
CVD 5 cardiovascular disease
MI 5 myocardial infarction
RR 5 relative risk
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tended to be slightly older, heavier and less physically active
and had a substantially higher prevalence of hypertension,
diabetes and hypercholesterolemia at baseline. Dietary fat
and cholesterol intakes did not differ appreciably across
categories of snoring.
After adjustment for age, both occasional and regular
snoring were associated with significantly increased risk of
CVD (Table 2). Compared with never snorers, the RRs of
CVD were 1.46 (95% CI 1.23 to 1.74) for occasional
snorers and 2.02 (1.62 to 2.53) for regular snorers. The
age-adjusted RRs of fatal CVD (including fatal MI and
stroke) were 1.61 (1.10 to 2.38) and 2.07 (1.25 to 3.43),
respectively. Snoring was associated with increased risk of
CHD, total stroke, ischemic stroke and hemorrhagic stroke
in the age-adjusted analysis.
After further adjusting for smoking, BMI and other
covariates, the positive associations for CVD were attenu-
ated but remained statistically significant (multivariate RRs
were 1.20 [1.01 to 1.43] for occasional snorers and 1.33
[1.06 to 1.67] for regular snorers). After additional adjust-
ment for history of hypertension, multivariate RRs of CVD
were 1.20 (1.01 to 1.42) for occasional snorers and 1.30
(1.03 to 1.64) for regular snorers. Further adjustment for
duration of shift work, marriage status and whether they
lived with a partner or spouse did not change these RRs.
Because snoring was strongly related to obesity (Table 1),
we were concerned about potential residual confounding by
BMI. However, when the analyses were repeated by includ-
ing deciles of BMI rather than quintiles in the model, the
results remained virtually the same. After adjustment for
snoring, neither the number of sleeping hours per day nor
usual sleep positions was significantly associated with risk of
CVD (data not shown). In further analyses, we observed a
positive association between snoring and CVD across dif-
ferent strata of BMI and smoking.
DISCUSSION
In this prospective study of women, we observed a modest
but significant positive association between snoring and
incidence of CVD. After accounting for age, smoking, BMI
and other cardiovascular risk factors, occasional snorers had
20% (95% CI 1% to 43%) increase in risk of CVD compared
with nonsnorers, while regular snorers had 33% (6% to 67%)
increase in risk.
Table 1. Baseline Characteristics and Risk Factors for Cardiovascular Disease According to Self-
Reported Snoring at Baseline in 1986
Characteristics
Frequency of Snoring
Never
(25%)
Occasionally
(65%)
Regularly
(10%)
Average # hours of sleeping/day 7.0 7.0 7.0
Usual sleep position (%)
On side 80 82 81
On back 6.3 6.5 8.3
On front 12.0 11.0 10.0
% of women
History of hypertension 18.3 24.5 33.5
History of diabetes 2.1 3.4 5.7
History of hypercholesterolemia 9.6 11.9 14.8
Current smoking 15.8 22.5 27.1
Parental history of MI 13.4 14.3 15.8
Multivitamin supplement use 44.4 42.1 39.4
Vitamin E supplement use 17.0 15.8 14.4
Night shift $5 yrs* 16.2 18.2 21.7
Mean
Age (yrs) 50.4 52.8 53.5
Body mass index (kg/m2) 23.0 24.4 26.8
Alcohol intake (g/day) 5.9 6.6 6.7
Physical activity (METS/week) 15.6 13.9 11.1
Saturated fat intake (% energy) 11.6 11.7 12.0
Polyunsaturated fat (% energy) 6.1 6.1 6.2
Trans fat (% energy) 1.7 1.7 1.7
Dietary cholesterol (mg/1,000 kcal) 149 151 156
Data were directly standardized to the age distribution of the entire study population.
METs 5 metabolic equivalents; MI 5 myocardial infarction.
*Reported in 1988.
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Strengths and limitations. The high rate of follow-up
reduced potential bias due to loss to follow-up. Further-
more, snoring and covariates were assessed prospectively,
eliminating possible bias due to retrospective recall which
may be present in case-control and cross-sectional analyses.
Since CVD may cause snoring (13), we excluded women
with cardiovascular end points at baseline. Women who
reported snoring regularly had a somewhat less healthy risk
profile (Table 1). After we controlled for smoking, BMI and
other covariates, the RRs were substantially attenuated,
reflecting confounding effects of these variables. However, a
significant positive association between snoring and CVD
persisted. Also, in stratified analyses by BMI and smoking,
the excess risk associated with snoring remained in all
subgroups.
Information on snoring and other potential risk factors
was self-reported by female nurses. The reliability of snoring
data was not validated in this population, but similar
questions about frequency of snoring have been validated in
other populations (20), in which self-reported habitual
snoring appeared to be reliable according to all-night sleep
recordings with monitoring of respiration, body move-
ments, oxygen saturation and snoring sound. Since all our
participants were registered, married nurses at entry with a
demonstrated interest in medical research, the possibility of
underreporting of snoring should be small relative to that in
general populations. Nevertheless, some misclassification of
the snoring variable was inevitable. Perhaps some women
were unaware of their snoring. However, the prevalence of
snoring did not appear to vary appreciably with marital
status or living arrangement in our cohort. Also, because
snoring was assessed prospectively, any misclassification of
Table 2. Relative Risks (95% Confidence Intervals) of Coronary Heart Disease and Stroke
According to Self-Reported Snoring at Baseline in 1986
Frequency of Snoring
Never Occasionally Regularly
Total cardiovascular events (coronary heart disease 1 stroke)**
# cases 162 729 151
Person-years 143,719 356,530 51,292
Age-adjusted 1.0 1.46 (1.23–1.74) 2.02 (1.62–2.53)
Multivariate 1.0 1.20 (1.01–1.43) 1.33 (1.06–1.67)
Fatal cardiovascular events
# cases 31 156 30
Age-adjusted 1.0 1.61 (1.10–2.38) 2.07 (1.25–3.43)
Multivariate 1.0 1.33 (0.90–1.96) 1.35 (0.80–2.26)
Coronary heart disease
# cases 102 441 101
Age-adjusted 1.0 1.43 (1.15–1.77) 2.18 (1.65–2.87)
Multivariate* 1.0 1.11 (0.89–1.39) 1.33 (1.00–1.77)
Total stroke
# cases 60 288 50
Age-adjusted 1.0 1.60 (1.21–2.12) 1.88 (1.29–2.74)
Multivariate 1.0 1.42 (1.07–1.89) 1.35 (0.91–1.99)
Ischemic stroke
# cases 38 176 37
Age-adjusted 1.0 1.51 (1.06–2.14) 2.14 (1.36–3.37)
Multivariate 1.0 1.31 (0.91–1.88) 1.42 (0.88–2.29)
Hemorrhagic stroke
# cases 16 79 13
Age-adjusted 1.0 1.77 (1.03–3.03) 1.97 (0.94–4.11)
Multivariate 1.0 1.71 (0.99–2.95) 1.80 (0.85–3.83)
*Models include the following: age (five-year category); time period (four periods); body mass index (five categories); cigarette
smoking (never, past and current smoking of 1 to 14, 15 to 24 and $25 cigarettes per day); menopausal status (premenopausal,
postmenopausal without hormone replacement, postmenopausal with past hormone replacement, postmenopausal with current
hormone replacement); parental history of myocardial infarction before 60 years of age; alcohol consumption (four categories);
multivitamin and vitamin E supplement use; physical activity (METS, in quintiles); average number hours of sleeping (5 h, 6,
7, 8, $9); usual sleep positions (on side, on back, on front); history of diabetes; history of hypercholesterolemia.
METs 5 metabolic equivalent hours.
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snoring frequency would be nondifferential with respect to
CVD, which, if present, would result in underestimation of
the effects of snoring.
Previous studies. Our findings among women are, in
general, consistent with previous studies of men. In a
prospective study of 4,388 men (3), 149 men were newly
diagnosed with ischemic heart disease, and 42 men were
diagnosed with stroke during three years of follow-up. After
adjusting for age, BMI, smoking and other cardiovascular
risk factors, the RRs comparing men who reported snoring
habitually or frequently with nonsnorers were 1.71 for
ischemic heart disease and 2.08 for ischemic heart disease
and stroke combined. In a cross-sectional study of 3,847
men and 3,664 women, Koskenvuo et al. (2) found a
significant association of self-reported habitual snoring with
risk of angina pectoris in men (RR 5 2.01) but a weak
association in women (RR 5 1.23). Several case-control
studies have reported a positive association of snoring with
risk of coronary disease or stroke (5,6,21), but the direction
of the association has been questioned because snoring can
be a consequence of CVD (8).
Biological mechanisms. The adverse effect of snoring on
risk of CVD may be mediated through obstructive sleep
apnea (22). In a series of heavy snoring patients (23), most
had increased apnea frequencies consistent with sleep apnea
syndrome. Sleep apnea has been directly associated with MI
(22) and stroke (5). Apnea is associated with hypoxemia,
which may accelerate atherosclerosis in coronary and intra-
cranial arteries (10). Also, sleep apnea may adversely affect
hematologic factors, such as decreasing fibrinolytic activity
(24). In addition, because of cyclical increase in sympathetic
output and systemic and pulmonary artery pressures due to
hemodynamic responses to obstructive apnea (9,25), sleep
apnea may directly cause systemic hypertension, a strong
risk factor for both CHD and stroke.
Because most snorers do not have sleep apnea, it is
unclear whether simple snoring without frank sleep apnea
may also increase the risk of CVD. In a cross-sectional study
among 580 adults from the Wisconsin Sleep Cohort Study,
Young et al. (26) found that simple snoring was significantly
associated with elevated blood pressure, independent of age,
gender and BMI; the magnitude of the association was
smaller than that for more severe sleep-disordered breath-
ing. The authors suggest that simple snoring represents the
beginning of the sleep-disordered breathing continuum,
which ranges from partial airway collapse and mildly in-
creased upper-airway resistance to complete airway collapse
and severe obstructive sleep apnea lasting 60 s or more (27).
Our study, like most of previous epidemiologic studies,
cannot distinguish the effects of simple snoring from snor-
ing with sleep apnea on the risk of CVD. However, we
observed a significant increase in risk of CVD, albeit small,
among occasional snorers who were most likely to be simple
snorers. These results support the notion that snoring
without sleep apnea may represent the beginning of the
sleep-disordered breathing continuum.
Conclusions. Our data suggest that snoring is associated
with a modest but significantly increased risk of CVD in
women, independent of age, smoking, obesity and other
cardiovascular risk factors. While further study is needed to
elucidate the biological mechanism underlying this associa-
tion, snoring may help clinicians identify individuals at
higher risk for CVD.
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